Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening

NCT02833298 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT02833298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02833298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2016
Completion date
April 1, 2018
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hcc, hcv, hepatitis c, hepatocellular carcinoma